Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgery
CTR20240885Phase 4Active
- Sponsor
- Hengrui Therapeutics
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Hengrui Therapeutics. Started May 2024; status: active.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20240885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240885.